300111 Stock Overview
Zhejiang Sunflower Great Health Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Zhejiang Sunflower Great Health Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.05 |
| 52 Week High | CN¥3.76 |
| 52 Week Low | CN¥1.83 |
| Beta | 0.28 |
| 11 Month Change | -0.65% |
| 3 Month Change | 41.86% |
| 1 Year Change | -8.41% |
| 33 Year Change | 6.64% |
| 5 Year Change | 33.77% |
| Change since IPO | -44.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300111 | CN Semiconductor | CN Market | |
|---|---|---|---|
| 7D | -1.0% | -2.7% | -0.9% |
| 1Y | -8.4% | 8.4% | 5.4% |
Return vs Industry: 300111 underperformed the CN Semiconductor industry which returned 8.4% over the past year.
Return vs Market: 300111 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
| 300111 volatility | |
|---|---|
| 300111 Average Weekly Movement | 11.1% |
| Semiconductor Industry Average Movement | 11.5% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300111's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300111's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 322 | Huaxin Shi | www.sunowe.com |
Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs worldwide. It offers clarithromycin API and tablets, an anti-infective drug used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, mycoplasma pneumoniae pneumonia, urethritis and cervicitis, as well as acute pharyngitis and acute tonsillitis; and azithromycin dispersible tablets for sinusitis, acute otitis media, acute bronchitis, acute exacerbation of chronic bronchitis, streptococcus pneumoniae, pneumonia, haemophilus influenzae, mycoplasma pneumoniae, urethritis, cervicitis and skin and soft tissue infection.
Zhejiang Sunflower Great Health Co., Ltd. Fundamentals Summary
| 300111 fundamental statistics | |
|---|---|
| Market cap | CN¥3.93b |
| Earnings (TTM) | CN¥600.90k |
| Revenue (TTM) | CN¥330.25m |
6,534x
P/E Ratio11.9x
P/S RatioIs 300111 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300111 income statement (TTM) | |
|---|---|
| Revenue | CN¥330.25m |
| Cost of Revenue | CN¥243.21m |
| Gross Profit | CN¥87.04m |
| Other Expenses | CN¥86.44m |
| Earnings | CN¥600.90k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.00047 |
| Gross Margin | 26.36% |
| Net Profit Margin | 0.18% |
| Debt/Equity Ratio | 1.1% |
How did 300111 perform over the long term?
See historical performance and comparison